The management of hyperuricemia associated with drug treatment of hypertension
Nakata, T.; Iimura, O.
Nihon Rinsho. Japanese Journal of Clinical Medicine 50 Suppl: 116-119
1992
ISSN/ISBN: 0047-1852 PMID: 1355121 Document Number: 400840
Document emailed within 1 workday
Related Documents
Mangini, R.J. 1979: Drug therapy reviews: pathogenesis and clinical management of hyperuricemia and gout American Journal of Hospital Pharmacy 36(4): 497-504Virdis, A.; Ghiadoni, L.; Taddei, S. 2014: Clinical management of drug-induced hypertension: 2013 Practical Recommendations of the Italian Society of Hypertension (SIIA) High Blood Pressure and Cardiovascular Prevention: the Official Journal of the Italian Society of Hypertension 21(1): 77-79
Tykarski, A. 1989: Hyperuricemia and arterial hypertension Polski Tygodnik Lekarski 44(30-31): 691-695
Wang, X.M.; Wang, X.Y.; Qian, W.Q. 1985: Hyperuricemia in patients with essential hypertension Zhonghua Nei Ke Za Zhi 24(12): 709
Hamada, T.; Hisatome, I.; Shigemasa, C. 2003: Drug-induced hyperuricemia Nihon Rinsho. Japanese Journal of Clinical Medicine 61(Suppl 1): 333-337
Niegowska, J.; Kucharska, A.; Gajewska, D. 2017: Hyperuricemia in obese patients with pharmacologically treated essential hypertension Wiadomosci Lekarskie 70(2 Part 2): 335-339
Milicević, Z.; Jelaković, B.; Marinković, M. 1994: Hyperuricemia and plasma renin activity in essential arterial hypertension Lijecnicki Vjesnik 116(1-2): 14-17
Aagaard, G.N. 1984: Management of hypertension in the elderly. The case for 'hygienic' measures over drug therapy Postgraduate Medicine 76(5): 61-67
Davis, M.Miller.; Jones, D.W. 2002: The role of lifestyle management in the overall treatment plan for prevention and management of hypertension Seminars in Nephrology 22(1): 35-43
Suzuki, H. 2015: Hypertension: The Points of Management of Hypertension for All Physicians--Based on the JSH 2014 Hypertension Guidelines--. Topics: VI. Pregnancy-induced hypertension Nihon Naika Gakkai Zasshi. Journal of the Japanese Society of Internal Medicine 104(2): 247-252
Yu, J.-w.; Lu, J.-b.; Zhang, X.-j.; Yang, Y.-b.; Yu, S.-y.; Liu, B.-l. 2005: Study on hyperuricemia with hyperlipaemia, high blood sugar and hypertension in 1320 elderly people Zhonghua Liu Xing Bing Xue Za Zhi 26(6): 455-457
Johannesson, M. 1996: The cost-effectiveness of hypertension treatment in Sweden: an analysis of the criteria for intervention and the choice of drug treatment Journal of Human Hypertension 10(Suppl 2): S23-S26
Widimský, Jří. 2015: PATHWAY-2 Study: spironolactone vs placebo, bisoprolol and doxazosin to determine optimal treatment of resistant hypertension. Spironolactone high effective in lowering blood pressure in drug resistant hypertension Vnitrni Lekarstvi 61(12): 1067-1071
1991: Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group JAMA 265(24): 3255-3264
Aagaard, G.N. 1970: Drug therapy. IV. the treatment of hypertension with complications Northwest Medicine 69(3): 167-169
Müting, D. 1978: Metabolic risk factors and their field of action. Incidence and therapy of hypertension, hyperuricemia, hyperlipidemia, diabetes mellitus, nicotine and alcohol abuse and obesity Fortschritte der Medizin 96(25): 1319-1322
Krzesinski, J.M. 2009: How to manage an arterial hypertension resistant to drug treatment Revue Medicale de Liege 64(3): 171-175
Shoshkes, M. 1974: The use of propranolol with various drug combinations in the treatment of essential hypertension Journal of the Medical Society of New Jersey 71(8): 581-583
Van Zwieten, P.A. 1980: Modern concepts in the drug treatment of arterial hypertension International Journal of Clinical Pharmacology Therapy and Toxicology 18(9): 412-419
Millar, J.A.; Waal-Manning, H.J. 1990: Minimum effective dosage in the drug treatment of hypertension New Zealand Medical Journal 103(892): 304